Gabriel Quiroz

Gabriel Quiroz

Auto-generated profile, based on publicly available information

Gabriel Quiroz

Servicio de Imágenes, Clínica Sanatorio Alemán

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2023 in Aging Cell
Verified
Journal Article
Open access
MAMacarena S. Arrázola
Macarena S. Arrázola
MLMatias Lira
Matias Lira
FVFelipe Véliz‐Valverde
Felipe Véliz‐Valverde
GQGabriel Quiroz
Gabriel Quiroz
SISomya Iqbal
Somya Iqbal
FCFelipe A. Court
Felipe A. Court
Age is the main risk factor for the development of neurodegenerative diseases. In the aged brain, axonal degeneration is an early pathological event, preceding neuronal dysfunction, and cognitive disabilities in humans, primates, rodents, and invertebrates. Necroptosis mediates degeneration of injured axons, but whether necroptosis triggers neurodegeneration and cognitive impairment along aging is unknown. Here, we show that the loss of the necroptotic effector Mlkl was sufficient to delay age‐associated axonal degeneration and neuroinflammation, protecting against decreased synaptic transmission and memory decline in aged mice. Moreover, short‐term pharmacologic inhibition of necroptosis targeting RIPK3 in aged mice, reverted structural and functional hippocampal impairment, both at the electrophysiological and behavioral level. Finally, a quantitative proteomic analysis revealed that necroptosis inhibition leads to an overall improvement of the aged hippocampal proteome, including a subclass of molecular biofunctions associated with brain rejuvenation, such as long‐term potentiation and synaptic plasticity. Our results demonstrate that necroptosis contributes to age‐dependent brain degeneration, disturbing hippocampal neuronal connectivity, and cognitive function. Therefore, necroptosis inhibition constitutes a potential geroprotective strategy to treat age‐related disabilities associated with memory impairment and cognitive decline.

3 December 2019 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
GQGabriel Quiroz
Gabriel Quiroz
Ramón Sotomayor-ZárateRamón Sotomayor-Zárate
Ramón Sotomayor-Zárate
JGJuan Pablo González Gutiérrez
Juan Pablo González Gutiérrez
FVFranco Vizcarra
Franco Vizcarra
FMFelipe Moraga
Felipe Moraga
PIPatricio Iturriaga-Vasquez
Patricio Iturriaga-Vasquez
Brain nicotinic acetylcholine receptors (nAChRs), a heterogeneous family of pentameric acetylcholine-gated cation channels, have been suggested as molecular targets for the treatment of alcohol abuse and dependence. Here, we examined the effect of the competitive nAChR antagonist UFR2709 on the alcohol consumption of high-alcohol-drinking UChB rats. UChB rats were given free access to ethanol for 24-h periods in a two-bottle free choice paradigm and their ethanol and water intake were measured. The animals were i.p. injected daily for 17 days with a 10, 5, 2.5, or 1 mg/kg dose of UFR2709. Potential confounding motor effects of UFR2709 were assessed by examining the locomotor activity of animals administered the highest dose of UR2709 tested (10 mg/kg i.p.). UFR2709 reduced ethanol consumption and ethanol preference and increased water consumption in a dose-dependent manner. The most effective dose of UFR2709 was 2.5 mg/kg, which induced a 56% reduction in alcohol consumption. Administration of UFR2709 did not affect the weight or locomotor activity of the rats, suggesting that its effects on alcohol consumption and preference were mediated by specific nAChRs.

11 November 2021 in bioRxiv
Verified
Preprint
Open access
MAMacarena S. Arrázola
Macarena S. Arrázola
MLMatias Lira
Matias Lira
GQGabriel Quiroz
Gabriel Quiroz
FVFelipe Véliz-Valverde
Felipe Véliz-Valverde
SISomya Iqbal
Somya Iqbal
FCFelipe A. Court
Felipe A. Court
Age is the main risk factor for the development of neurodegenerative diseases. In the aged brain, axonal degeneration is an early pathological event, preceding neuronal dysfunction, and cognitive disabilities in humans, primates, rodents, and invertebrates. Necroptosis mediates degeneration of injured axons, but whether necroptosis triggers neurodegeneration and cognitive impairment along aging is unknown. Here we show that the loss of the necroptotic effector Mlkl was sufficient to delay age-associated axonal degeneration and neuroinflammation, protecting against decreased synaptic transmission and memory decline in aged mice. Moreover, short-term pharmacologic inhibition of necroptosis in aged mice reverted structural and functional hippocampal impairment, both at the electrophysiological and behavioral level. Finally, a quantitative proteomic analysis revealed that necroptosis inhibition leads to an overall improvement of the aged hippocampal proteome, including a subclass of molecular biofunctions associated with brain rejuvenation, such as long-term potentiation and synaptic plasticity. Our results demonstrate that necroptosis contributes to the age-dependent brain degeneration, disturbing hippocampal neuronal connectivity, and cognitive function. Therefore, necroptosis inhibition constitutes a potential geroprotective strategy to treat age-related disabilities associated with memory impairment and cognitive decline.

16 October 2023 in Revista chilena de obstetricia y ginecología
Verified
Journal Article
Open access
PDF file
FVFernando Viñals
Fernando Viñals
LHLorena Hormazábal
Lorena Hormazábal
CVCatalina Viñals
Catalina Viñals
GQGabriel Quiroz
Gabriel Quiroz
BZBelkys Zambrano
Belkys Zambrano
LDLinder Díaz
Linder Díaz
Introducción: Los quistes interhemisféricos asociados a agenesia del cuerpo calloso constituyen un grupo infrecuente y heterogéneo de anomalías del SNC. Objetivo: Reportar nuestra experiencia en quistes interhemisféricos asociados a agenesia del cuerpo calloso (QIH/ACC), haciendo énfasis en sus características en la neurosonografía (NSG), su comparación con la resonancia magnética (RM) y su evolución clínica posterior. Método: Se incluyeron todas las pacientes con QIH/ACC evaluadas desde el año 2008. En todos los casos se consignaron los datos clínicos, de NSG y de RM cuando se realizó. Se entrevistó telefónicamente a los padres. Resultados: Fueron seleccionados 9 casos con QIH/ACC. De ellos, 5 fueron quistes tipo 1, 3 tuvieron anomalías asociadas y en los 3 hubo una anomalía genética patogénica. Cuatro casos fueron quistes tipo 2, 3 de ellos con un patrón NSG sugerente de síndrome de Aicardi. Hubo una excelente correlación entre NSG y RM, ya fuera esta última realizada ante-o posnatal, particularmente con relación a las malformaciones del desarrollo cortical asociadas al QIH/ACC. Conclusiones: En comparación con la RM y el resultado final, hubo alta concordancia con lo diagnosticado en la NSG, en especial en cuanto a malformaciones del desarrollo cortical asociadas, lo que añade valor al método diagnóstico que

19 December 2023 in Revista chilena de obstetricia y ginecología
Verified
Journal Article
Open access
PDF file
FVFernando Viñals
Fernando Viñals
LHLorena Hormazábal
Lorena Hormazábal
CVCatalina Viñals
Catalina Viñals
GQGabriel Quiroz
Gabriel Quiroz
BZBelkys Zambrano
Belkys Zambrano
LDLinder Díaz
Linder Díaz
Objetivo: Reportar el resultado a largo plazo de una serie de fetos con agenesia del septum pellucidum aislada (ASP), con medición de su quiasma &oacu...